Skip to main content
. 2020 Dec 23;58(6):436–443. doi: 10.5114/reum.2020.102010

Table I.

Clinical features and treatment of reported patients

Feature Case 1 Case 2 Case 3 Case 4
Gender Male Female Female Female
Age, years 3 6 12 1 year 4 months
Quotidian fever Yes Yes Yes Yes
Typical evanescent rash Yes Yes No Yes
Hepatomegaly Yes Yes Yes Yes
Splenomegaly Yes No Yes* Yes*
Lymphadenopathy Yes Yes Yes* Yes
Pericarditis Yes* Yes Yes* No
Pleuritis No Yes No No
Abdominal pain Yes No No No
Arthritis Yes Yes Yes* No
Arthralgia Yes Yes Yes Yes
MAS Yes No No No
Treatment to achieve remission MPS IV, MPS PO MPS IV pulse, MPS PO, MTX, tocilizumab MPS PO, MTX MPS IV, MPS PO
Flares Yes Yes No Yes

MPS IV – methylprednisolone intravenous, MPS PO – methylprednisolone per os, MTX – methotrexate.

*

Signs were revealed by instrumental examination.